An effect of physostigmine on the central nervous system of rabbits, related to brain levels of norepinephrine.
D000818:Animals; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D002395:Catecholamines / Q000037:antagonists & inhibitors; D002490:Central Nervous System / Q000187:drug effects / Q000502:physiology*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004347:Drug Interactions; D004569:Electroencephalography; D005071:Evoked Potentials; D007275:Injections, Intravenous; D008297:Male; D009638:Norepinephrine / Q000032:analysis* / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D010830:Physostigmine / Q000008:administration & dosage / Q000494:pharmacology*; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D013997:Time Factors; D014443:Tyrosine / Q000494:pharmacology
D002395:Catecholamines; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D010293:Pargyline; D010830:Physostigmine; D009638:Norepinephrine